Search This Blog

Wednesday, August 7, 2019

Amphastar Pharmaceuticals EPS beats by $0.03, beats on revenue

Amphastar Pharmaceuticals (NASDAQ:AMPH): Q2 Non-GAAP EPS of $0.08 beats by $0.03; GAAP EPS of $0.96.
Revenue of $79.05M (+11.3% Y/Y) beats by $0.15M.
Press Release
Posted by at

No comments:

Post a Comment

Note: Only a member of this blog may post a comment.

Subscribe to: Post Comments (Atom)